Double-masked Study of Netarsudil (AR-13324) Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension

Clinical trial NCT02558374 · COMPLETED

Trial details

NCT number: NCT02558374
Sponsor: Aerie Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Open-angle Glaucoma Ocular Hypertension

Start date: 2015-09-01
Primary completion: 2016-12-01
Enrollment: 708

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.